Epidemiología y factores de riesgo asociados a displasia broncopulmonar en prematuros menores de 32 semanas de edad gestacional

Alonso, Andrea Sucasas; Díaz, Sonia Pértega; Soto, Rebeca Sáez; Ávila-Álvarez, Alejandro

doi:10.1016/j.anpedi.2021.03.002

Cited by 7 publications

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020

Packnett

Winer

Larkin

et al. 2022

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis and pneumonia in children under one year and a leading cause of infant hospitalization. Palivizumab was approved by the FDA in 1998 as RSV immunoprophylaxis to prevent severe RSV disease in children with specific health conditions and those born at <35 weeks gestational age (wGA). This study compared RSV-related hospitalization (RSVH) and RSVH characteristics in very preterm (<29 wGA) and term (>37 wGA) infants. Using the MarketScan Commercial and Multi-State Medicaid administrative claims databases, infants born between 7/1/2003 and 6/30/2020 were identified and classified as very preterm or term. Infants with evidence of health conditions, such as congenital heart disease and cystic fibrosis, were excluded. During 2003–2020 RSV seasons (November to March), claims incurred by infants while they were <12 months old were evaluated for outpatient administration of palivizumab and RSVH. The study included 40,123 very preterm infants and 4,421,942 term infants. Rate of RSVH in very preterm infants ranged 1.5–3.8 per 100 infant-seasons in commercially insured infants and 3.5–8.4 in Medicaid insured infants and were inversely related to wGA at birth. Relative risk of RSVH in very preterm was 3–4 times higher, and ICU admissions and mechanical ventilation were more common during RSVH in very preterm infants relative to term infants. However, these outcomes were less common or less severe in very preterm infants who received outpatient palivizumab administration, despite evidence of higher baseline risk of RSVH in these infants.

show abstract

RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020

Packnett

Winer

Larkin

et al. 2022

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

show abstract

Pathology Detector System in the Bronchopulmonary System of Asthmatic patients visualized through a radiofrequency of the chest

Perez-Siguas¹,

Matta-Solis²,

Remuzgo-Artezano³

et al. 2023

2023 Third International Conference on Advances in Electrical, Computing, Communication and Sustainable Technologies (ICAECT)

View full text Add to dashboard Cite

Incidência e fatores associados à displasia broncopulmonar em egressos de Unidades de Terapia Intensiva Neonatal no norte de Minas Gerais

Menezes,

Dias,

Araújo

et al. 2024

Rev. Bras. Saude Mater. Infant.

View full text Add to dashboard Cite

Resumo Objetivos: avaliar a incidência e fatores associados à displasia broncopulmonar (DBP) em egressos de Unidades de Terapia Intensiva Neonatal (UTIN). Métodos: estudo de coorte retrospectivo com prematuros egressos de UTIN. O processo amostral foi aleatório, considerando crianças em seguimento em ambulatório de alto risco com registro em UTIN no período de 2014 a 2018. A coleta foi realizada a partir de prontuários e entrevistas com as mães ou responsáveis, com informações referentes às intercorrências durante a gestação, condições de nascimento, cuidados e morbidades na UTIN. A DBP foi aferida para neonatos com utilização de oxigenioterapia por períodoigual ou superior a 28 dias ou 36 semanas de idade gestacional corrigida. Após análises bivariadas, seguiu-se análise de regressão logística binária. Para o modelo final definiu-se nível de significância de 5% (p<0,05), com registro das respectivas Odds Ratio e intervalos de confiança de 95%. Resultados: foram avaliados dados de 293 prematuros, predominantemente do sexo masculino (55,6%) e idade gestacional de 32 a 36 semanas. A DBP foi registrada para 63 crianças (21,5%). As variáveis que permaneceram estatisticamente associadas à DBP foram: peso de nascimento, idade gestacional e registro de sepse tardia. Conclusões: registrou-se elevada incidência de DBP. Os fatores associados destacam a necessidade de melhoria dos cuidados pré e pós-natais

show abstract

Epidemiología y factores de riesgo asociados a displasia broncopulmonar en prematuros menores de 32 semanas de edad gestacional

Cited by 7 publications

References 39 publications

RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020

RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020

Pathology Detector System in the Bronchopulmonary System of Asthmatic patients visualized through a radiofrequency of the chest

Incidência e fatores associados à displasia broncopulmonar em egressos de Unidades de Terapia Intensiva Neonatal no norte de Minas Gerais

Contact Info

Product

Resources

About